Latest Foresite Capital Management IV, LLC Stock Portfolio
$197Million
Equity Portfolio Value
Last Reported on: 13 Feb, 2024
About Foresite Capital Management IV, LLC and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Foresite Capital Management IV, LLC reported an equity portfolio of $197.9 Millions as of 31 Dec, 2023.
The top stock holdings of Foresite Capital Management IV, LLC are PHVS, KURA, KNTE. The fund has invested 57.2% of it's portfolio in PHARVARIS N.V. and 13.4% of portfolio in KURA ONCOLOGY, INC.
The fund managers got completely rid off CYMABAY THERAPEUTICS, INC. (CBAY) and ACLARIS THERAPEUTICS, INC. (ACRS) stocks. They significantly reduced their stock positions in LYELL IMMUNOPHARMA, INC. (LYEL). The fund showed a lot of confidence in some stocks as they added substantially to PHARVARIS N.V. (PHVS).
The top stock holdings of Foresite Capital Management IV, LLC are PHVS, KURA, KNTE. The fund has invested 57.2% of it's portfolio in PHARVARIS N.V. and 13.4% of portfolio in KURA ONCOLOGY, INC.
The fund managers got completely rid off CYMABAY THERAPEUTICS, INC. (CBAY) and ACLARIS THERAPEUTICS, INC. (ACRS) stocks. They significantly reduced their stock positions in LYELL IMMUNOPHARMA, INC. (LYEL). The fund showed a lot of confidence in some stocks as they added substantially to PHARVARIS N.V. (PHVS).
New Buys
Additions
| Ticker | % Inc. |
|---|---|
| PHARVARIS N.V. | 7.89 |
Additions to existing portfolio by Foresite Capital Management IV, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| LYELL IMMUNOPHARMA, INC. | -5.23 |
Foresite Capital Management IV, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| ACLARIS THERAPEUTICS, INC. | -19,235,000 |
| CYMABAY THERAPEUTICS, INC. | -26,645,600 |
Foresite Capital Management IV, LLC got rid off the above stocks
Current Stock Holdings of Foresite Capital Management IV, LLC
Last Reported on: 13 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ACRS | ACLARIS THERAPEUTICS, INC. | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CBAY | CYMABAY THERAPEUTICS, INC. | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| KNTE | KINNATE BIOPHARMA INC. | 11.58 | 9,671,640 | 22,921,800 | UNCHANGED | 0.00 | |
| KURA | KURA ONCOLOGY, INC. | 13.44 | 1,849,950 | 26,602,200 | UNCHANGED | 0.00 | |
| LYEL | LYELL IMMUNOPHARMA, INC. | 8.16 | 8,325,000 | 16,150,500 | REDUCED | -5.23 | |
| PHVS | PHARVARIS N.V. | 57.25 | 4,038,840 | 113,290,000 | ADDED | 7.89 | |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 9.56 | 875,000 | 18,908,800 | UNCHANGED | 0.00 |